Recordati Seeks Ex-Italy Growth In Orphan Drugs, Emerging Markets And OTCs
This article was originally published in PharmAsia News
Executive Summary
Italy’s Recordati plans to globalize its orphan drugs business and will target Russia, Turkey and markets in Central and Eastern Europe for its primary care prescription and OTC products.